Centre for Statistical and Methodological Excellence (CESAME): A Consortium Initiative for Improving Methodology in Randomised Clinical Trials

Caroline Kamp Jørgensen*, Markus Harboe Olsen, Niklas Nielsen, Theis Lange, Lawrence Mbuagbaw, Lehana Thabane, Laurent Billot, Nadine Binder, Silvio Garattini, Rita Banzi, Jacques Demotes, Elena Biagioli, Eliana Rulli, Guido Bertolini, Giovanni Nattino, Ole Mathiesen, Valter Torri, Christian Gluud, Janus Christian Jakobsen

*Corresponding author for this work

Abstract

When conducting randomised clinical trials, the choice of methodology and statistical analyses will influence the results. If the planned methodology is not of optimal quality and predefined in detail, there is a risk of biased trial results and interpretation. Even though clinical trial methodology is already at a very high standard, there are many trials that deliver biased results due to the implementation of inadequate methodology, poor data quality and erroneous or biased analyses. To increase the internal and external validity of randomised clinical trial results, several international institutions within clinical intervention research have formed The Centre for Statistical and Methodological Excellence (CESAME). Based on international consensus, the CESAME initiative will develop recommendations for the proper methodological planning, conduct and analysis of clinical intervention research. CESAME aims to increase the validity of randomised clinical trial results which will ultimately benefit patients worldwide across medical specialities. The work of CESAME will be performed within 3 closely interconnected pillars: (1) planning randomised clinical trials; (2) conducting randomised clinical trials; and (3) analysing randomised clinical trials.

Original languageEnglish
Article number11786329231166519
JournalHealth services insights
Volume16
ISSN1178-6329
DOIs
Publication statusPublished - 2023

Fingerprint

Dive into the research topics of 'Centre for Statistical and Methodological Excellence (CESAME): A Consortium Initiative for Improving Methodology in Randomised Clinical Trials'. Together they form a unique fingerprint.

Cite this